Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected

Proceedings of the jubilee Twenty-Fifth International Symposium on Blood Transfusion, Groningen, 2000, Organized by the Sanquin Division Blood Bank Noord Nederland

AvC.Th. Smit Sibinga,J.D. Cash

Inbunden, Engelska, 2001

Del i serien Developments in Hematology and Immunology

1 637 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This volume is the proceedings of the 25th Jubilee International Symposium on Blood Transfusion and reviews what has been achieved and what can be expected. There have been many achievements during the last quarter of the 20th century - for example the Landsteiner discovery of red cell markers and the Huestin development of an appropriate anticoagulant. The proceedings of this symposium offer information on the future of this evolving field of medicine. The material is presented in four sections: blood supply systems and organization; technical and pharmaceutical developments; quality principles and risk management; and transfusion medicine for the patient. The text provides a comprehensive review of this area, along with possible future directions.

Produktinformation

Utgivningsdatum:2001-09-30
Mått:155 x 235 x 23 mm
Vikt:653 g
Format:Inbunden
Språk:Engelska
Serie:Developments in Hematology and Immunology
Antal sidor:304
Upplaga:2001
Förlag:Kluwer Academic Publishers
ISBN:9781402000799

Utforska kategorier

Hematologi inom Medicin

Innehållsförteckning

I. Blood Supply Systems and Organisation.- Blood Transfusion: Quo Vadis? Customer Orientation as the Leading Principal for Blood Banks in the Future.- Community Involvement: The Development, the Past – the Present and the Future of Blood Donations as a Form of Community Involvement.- Structure and Commitments – Blood Supply Systems and Organization.- Applying Decision Analysis to Transfusion Medicine in the Real World to Improve Transfusion Safety.- Cost-Effectiveness of HIV NAT Screening for Dutch Donors.- Legal and Regulatory Aspects of Blood Transfusion.- Discussion.- II. Technical and Pharmaceutical Developments.- Freezing and Vitrification of Red Cells, Recollections and Predictions.- Plasma Fractionation.- Inactivation of Viruses, Bacteria, Protozoa, and Leukocytes in Labile Blood Components by Using Nucleic Acid Targeted Methods.- Alternatives to Human Blood Resources.- Discussion.- III. Quality Principles and Risk Management.- Quality Systems and Management: 2000 Where Have We Been and Where Are We Going?.- Traceability and Coding Principles.- Quality Principles and Risk Management: Automation and Documentation.- Haemovigilance.- Human Resources: Teaching and Training in Transfusion Medicine.- Discussion.- IV. Transfusion Medicine at the Bedside.- The Epidemiology of Blood Component Transfusion in South Eastern Scotland, 1990 to 1997.- Contributions of Meta-Analysis to Transfusion Medicine.- Immunomodulation: Facts and Interpretations.- Development and Implementation of New Cellular Therapies.- Transfusion Medicine and the Development of Gene Therapy.- Making Policy in the 2000s.- Discussion.